Trial Profile
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Tamsulosin (Primary) ; Tolterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms COBALT
- 13 Jan 2020 Results published in the JAMA Internal Medicine
- 27 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Apr 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.